ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 668254 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 668254; 2) Community: the network communities that were significantly associated with the response to NSC 668254; 3) Molecule: the relationships between components within communities and NSC 668254; 4) MDR: the compounds that were significantly associated with the NSC 668254.

NSC Compound Enrichment Correlation
NSC 275647 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-8-(methoxyacetyl)-, hydrochloride, (8S-cis)- 0.0385613993886001 0.26398988
NSC 300289 Pinafide 0.0385613993886001 0.11540147
NSC 301457 Cycloalkannin 0.0385613993886001 0.77549079
NSC 30722 Pyrimidine, 2,4,6-trichloro-5-methyl- 0.0385613993886001 0.56191152
NSC 328410 Camptothecin Derivative 0.0385613993886001 -0.045649222
NSC 331935 CHALCONE ANALOG 0.0385613993886001 0.29959999
NSC 339579 7H-Pyrrolo[3,2-f]quinazoline-2,4-diamine, 7-[(3-nitrophenyl)methyl]-, monoacetate 0.0385613993886001 0.12050515
NSC 351521 Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) 0.0385613993886001 0.20648459
NSC 354974 Acetamide, N-(5,6,7,9-tetrahydro-2,3-dihydroxy-1,10-dimethoxy-9-oxobenzo[a]heptalen-7-yl)-, (S)- 0.0385613993886001 0.125967
NSC 363787 Kaur-16-en-15-one,1,3,7,11-tetrakis(acetyloxy)-12-hydroxy-, (1.alpha.,3.beta.,7.beta.,11.beta.,12.alpha.)- 0.0385613993886001 0.69116527
Total:121  Current:87    [First] [Prev] [Next] [Last]